The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I think this lesson should help to create less euphoria around the possibilities of onboarding clients such as Unilever - what would happen if ITX were too reliant on one very large client? We have to assume John and his team know what they are doing - doubtless as in any negotiations there would be some scope for give and take, but if a larger client tries to flex their muscles too much, it cannot be good for the relationship going forward, unless a compromise can be reached.
think there should be some context to the discussion.
suspension was when photonstar/bould effectively became a shell company.
cizzle is for all intents and purposes a different company and with different directors to the old trading company.
that said, communication is now so sp**** and poor that it really feels dismissive.
all can be forgiven if there is a surpassingly good end to the story, but not if the opposite is true.
all imho
It would be good to hear what they have achieved over the past few months, and to get a definitive time line of where they expect to be and when.
We really need to know - and very soon - what progress is being made with commercialisation as well as R&D.
This is clearly what was hoped for. Does anybody have an idea when we might hear about likely recoverable volumes? Are we saying a couple of weeks, or wait for further drill results?.. or further tests?
Surely Helium coming to surface at the stated rate means there should be some recoverable volume for a relative certainty? Looks to be brilliant so far.
IMHO
Strange that the CDT premarket trading has started so strongly, and now 3m shares traded.
Wonder if that will translate into a real time share price advancement, or if it is just volatility that will settle into the opening bell.